Scholarlink

Objectives <p>To analyze changes in the liver dual-energy CT fat fraction (liver DECT FF) at the intensive care unit (ICU), and its prognostic value.</p> Materials and methods <p>Intubated ICU patients were retrospectively included, who received two clinical DECT (CT1 and CT2) within a minimum interval of 10 days between 11/2019 and 12/2022. The liver DECT FF was determined by combining two regions of interest (ROI) in the right and one ROI in the left liver lobe (minimum area 3.6 cm<sup>2</sup>). The skeletal muscle index, muscle radiodensity attenuation, subcutaneous/visceral adipose tissue area, and waist circumference were assessed. Pre-existing diseases, reasons for ICU admission, ICU scoring systems, and in-hospital mortality were noted. <i>t</i>-tests, Wilcoxon tests, linear or Cox regression, Pearson correlation, and intraclass correlation coefficients (ICC) were employed.</p> Results <p>Of 76 total patients, 43.4% were female (age 61 ± 12 years) and 97.4% received parenteral nutrition. In-hospital mortality was 60.8%. The liver DECT FF at CT1 was the only parameter associated with in-hospital mortality (hazard ratio: 1.15 [95% confidence interval: 1.07–1.24], <i>p</i> &lt; 0.001), and a shorter ICU stay (−3.66 [−6.29 to −1.02] days, <i>p</i> &lt; 0.007). DECT FF was not associated with ICU scoring systems. It did not relevantly change within a median of 8 days (3.3 ± 5.5% at CT1; 2.7 ± 4.3% at CT2, <i>p</i> = 0.315). Subset inter-observer reproducibility was good (ICC: 0.87 [0.66–0.95]).</p> Conclusion <p>The liver DECT FF may serve as an independent prognostic imaging biomarker of mortality in critically ill patients, with a superior value to single-energy body composition parameters.</p> Key Points <p><Emphasis Type="BoldItalic">Question</Emphasis> <i>Although the risk of liver steatosis is increased in critically ill patients, it is unknown if liver fat content, when quantified using DECT, is of prognostic value</i>.</p> <p><Emphasis Type="BoldItalic">Findings</Emphasis> <i>The liver DECT FF is associated with in-hospital mortality in critically ill patients</i>.</p> <p><Emphasis Type="BoldItalic">Clinical relevance</Emphasis> <i>The liver DECT FF may be superior for survival prognosis than single-energy CT body composition parameters of muscle and fat tissue at the ICU</i>.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dual-energy CT liver fat fraction as prognostic imaging biomarker in critically ill patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月6日

查看全文
  • Jennifer Erley,
  • Julia Breckow,
  • Kevin Roedl,
  • Ann-Kathrin Ozga,
  • Alidan Duoerkongjiang,
  • Geraldine de Heer,
  • Niklas Schubert,
  • Fabian Pallasch,
  • Christoph Burdelski,
  • Stefan Kluge,
  • Jin Yamamura,
  • Gerhard Adam,
  • Isabel Molwitz

摘要

Objectives

To analyze changes in the liver dual-energy CT fat fraction (liver DECT FF) at the intensive care unit (ICU), and its prognostic value.

Materials and methods

Intubated ICU patients were retrospectively included, who received two clinical DECT (CT1 and CT2) within a minimum interval of 10 days between 11/2019 and 12/2022. The liver DECT FF was determined by combining two regions of interest (ROI) in the right and one ROI in the left liver lobe (minimum area 3.6 cm2). The skeletal muscle index, muscle radiodensity attenuation, subcutaneous/visceral adipose tissue area, and waist circumference were assessed. Pre-existing diseases, reasons for ICU admission, ICU scoring systems, and in-hospital mortality were noted. t-tests, Wilcoxon tests, linear or Cox regression, Pearson correlation, and intraclass correlation coefficients (ICC) were employed.

Results

Of 76 total patients, 43.4% were female (age 61 ± 12 years) and 97.4% received parenteral nutrition. In-hospital mortality was 60.8%. The liver DECT FF at CT1 was the only parameter associated with in-hospital mortality (hazard ratio: 1.15 [95% confidence interval: 1.07–1.24], p < 0.001), and a shorter ICU stay (−3.66 [−6.29 to −1.02] days, p < 0.007). DECT FF was not associated with ICU scoring systems. It did not relevantly change within a median of 8 days (3.3 ± 5.5% at CT1; 2.7 ± 4.3% at CT2, p = 0.315). Subset inter-observer reproducibility was good (ICC: 0.87 [0.66–0.95]).

Conclusion

The liver DECT FF may serve as an independent prognostic imaging biomarker of mortality in critically ill patients, with a superior value to single-energy body composition parameters.

Key Points

Question Although the risk of liver steatosis is increased in critically ill patients, it is unknown if liver fat content, when quantified using DECT, is of prognostic value.

Findings The liver DECT FF is associated with in-hospital mortality in critically ill patients.

Clinical relevance The liver DECT FF may be superior for survival prognosis than single-energy CT body composition parameters of muscle and fat tissue at the ICU.

Graphical Abstract